Geode Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-127,771
| Closed | -$53K | – | 4225 |
|
|
2018
Q4 | $53K | Buy |
127,771
+80,645
| +171% | +$50.1K | ﹤0.01% | 3982 |
|
|
2018
Q3 | $45K | Hold |
47,126
| – | – | ﹤0.01% | 4036 |
|
|
2018
Q2 | $114K | Buy |
47,126
+7,531
| +19% | +$18.4K | ﹤0.01% | 3850 |
|
|
2018
Q1 | $94K | Sell |
39,595
-218
| -0.5% | -$550 | ﹤0.01% | 3856 |
|
|
2017
Q4 | $95K | Hold |
39,813
| – | – | ﹤0.01% | 3831 |
|
|
2017
Q3 | $125K | Hold |
39,813
| – | – | ﹤0.01% | 3781 |
|
|
2017
Q2 | $160K | Buy |
39,813
+2,418
| +6% | +$10.5K | ﹤0.01% | 3749 |
|
|
2017
Q1 | $138K | Buy |
37,395
+72
| +0.2% | +$226 | ﹤0.01% | 3760 |
|
|
2016
Q4 | $72K | Buy |
37,323
+50
| +0.1% | +$181 | ﹤0.01% | 3852 |
|
|
2016
Q3 | $231K | Buy |
37,273
+16,319
| +78% | +$101K | ﹤0.01% | 3546 |
|
|
2016
Q2 | $93K | Sell |
20,954
-4,358
| -17% | -$28.4K | ﹤0.01% | 3817 |
|
|
2016
Q1 | $265 | Buy |
25,312
+2,110
| +9% | +$41.9K | ﹤0.01% | 3527 |
|
|
2015
Q4 | $683K | Buy |
23,202
+677
| +3% | +$20.5K | ﹤0.01% | 3108 |
|
|
2015
Q3 | $711K | Buy |
22,525
+631
| +3% | +$30.2K | ﹤0.01% | 3059 |
|
|
2015
Q2 | $1.3M | Buy |
21,894
+3,747
| +21% | +$264K | ﹤0.01% | 2763 |
|
|
2015
Q1 | $1.94M | Buy |
18,147
+2,440
| +16% | +$233K | ﹤0.01% | 2461 |
|
|
2014
Q4 | $1.47M | Buy |
15,707
+1,917
| +14% | +$183K | ﹤0.01% | 2612 |
|
|
2014
Q3 | $1.06M | Buy |
13,790
+3,275
| +31% | +$258K | ﹤0.01% | 2744 |
|
|
2014
Q2 | $943K | Buy |
10,515
+5,207
| +98% | +$319K | ﹤0.01% | 2842 |
|
|
2014
Q1 | $283K | Sell |
5,308
-141
| -3% | -$4.65K | ﹤0.01% | 3380 |
|
|
2013
Q4 | $137K | Buy |
5,449
+177
| +3% | +$4.22K | ﹤0.01% | 3529 |
|
|
2013
Q3 | $144K | Buy |
5,272
+1,108
| +27% | +$35.7K | ﹤0.01% | 3418 |
|
|
2013
Q2 | $150K | Buy |
+4,164
| New | +$156K | ﹤0.01% | 3327 |
|
Geode Capital Management's PTX Position: Q1 2019 in Review
Geode Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 127,771 shares — an estimated $53K sold.
Geode Capital Management first reported a position in PTX in Q2 2013 and held it in 23 quarters. The position peaked at $1.94M in Q1 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Geode Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Geode Capital Management sold 127,771 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $53K.
- Geode Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 23 quarters.
- Geode Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $1.94M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Geode Capital Management's 13F filing for Q1 2019, filed 14 May 2019.